SCHEMBL4059068

SCHEMBL4059068

Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)N4CCN(Cc5ccc(C#N)cc5)CC4)cc3)cc2n(C)c1=O

nearest known ligand 0.83

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 18/20 0.83
ADORA1 P30542 9/20 0.83
ADORA3 P0DMS8 7/20 0.83
ADORA2A P29274 4/20 0.53
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4061797 0.91 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4058557 0.91 ADORA2B (0.88) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4055264 0.89 ADORA2B (0.85) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4052662 0.89 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4052844 0.89 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4057447 0.88 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4054165 0.87 ADORA2B (0.79) ADORA2BADORA1ADORA3ADORA2AMEN1
SCHEMBL4053807 0.87 ADORA2B (0.81) ADORA2BADORA1ADORA3ADORA2AALDH1A1
SCHEMBL4054044 0.87 ADORA2B (0.81) ADORA2BADORA1ADORA3ADORA2ASMN1; SMN2
SCHEMBL4051740 0.87 ADORA2B (1.00) ADORA2BADORA1ADORA3ADORA2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed